BlackRock Investment Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $8K | Hold |
2,889
| – | – | ﹤0.01% | 3649 |
|
|
2016
Q3 | $17K | Buy |
2,889
+307
| +12% | +$1.81K | ﹤0.01% | 3374 |
|
|
2016
Q2 | $8K | Sell |
2,582
-50,335
| -95% | -$156K | ﹤0.01% | 3711 |
|
|
2016
Q1 | $284K | Buy |
52,917
+956
| +2% | +$5.13K | ﹤0.01% | 3074 |
|
|
2015
Q4 | $617K | Buy |
51,961
+75
| +0.1% | +$891 | ﹤0.01% | 2902 |
|
|
2015
Q3 | $426K | Sell |
51,886
-1,311
| -2% | -$10.8K | ﹤0.01% | 3077 |
|
|
2015
Q2 | $742K | Buy |
53,197
+42,739
| +409% | +$596K | ﹤0.01% | 2964 |
|
|
2015
Q1 | $251K | Sell |
10,458
-237
| -2% | -$5.69K | ﹤0.01% | 3162 |
|
|
2014
Q4 | $176K | Hold |
10,695
| – | – | ﹤0.01% | 3257 |
|
|
2014
Q3 | $136K | Sell |
10,695
-65
| -0.6% | -$827 | ﹤0.01% | 3268 |
|
|
2014
Q2 | $243K | Buy |
10,760
+916
| +9% | +$20.7K | ﹤0.01% | 3204 |
|
|
2014
Q1 | $278K | Buy |
+9,844
| New | +$278K | ﹤0.01% | 3163 |
|